(Q42212681)
Statements
1 reference
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV. (English)
1 reference
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV (English)
0 references
Patrick Marcellin
1 reference
Maribel Rodriguez-Torres
1 reference
Eric M Yoshida
1 reference
Subasree Srinivasan
1 reference
Vivek S Purohit
1 reference
Cunshan Wang
1 reference
Jennifer L Hammond
1 reference
1 July 2014
1 reference
July 2014
0 references
13
1 reference
4
1 reference
364-375
1 reference
Identifiers
1 reference